Moreover, the expression of ALG3 in tumor-infiltrating immune cells (TIICs) was also significantly associated with tumor number (P ≤ 0.0001), CNLC stage (P = 0.022), and TNM stage (P = 0.027) (Table 1). The gene discussed is ALG3; the disease is neoplasm.